The Development of a Parenteral Pharmaceutical Formulation of a New Class of Compounds of Nitrosourea
Despite the rapid development of medical technologies, chemotherapy treatment still occupies an important place in clinical oncology. In this regard, the current research in this area focuses on the synthesis of new highly effective antitumor substances that have minimal side effects and the develop...
Saved in:
Main Authors: | Ludmila Nikolaeva (Author), Natalia Oborotova (Author), Natalia Bunyatyan (Author), Xi Zhang (Author), Ekaterina Sanarova (Author), Anna Lantsova (Author), Olga Orlova (Author), Alevtina Polozkova (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MODERN ONCO DRUG FOR INTERNAL USE
by: O. L. Orlova, et al.
Published: (2018) -
ANALYSIS POLYVINYLPYRROLIDONE IN DOSAGE FORMS
by: L. L. Nikolaeva, et al.
Published: (2016) -
Antiproliferative activity of a new derivative from the class of N-glycoside of indolo[2,3-a]pyrrolo[3,4-c]carbazoles
by: Marina P. Kiseleva, et al.
Published: (2022) -
A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment
by: Anna Lantsova, et al.
Published: (2021) -
Involvement of neuronal nitric oxide synthase in N-methyl-N-nitrosourea-induced retinal degeneration in mice
by: Yoshiki Koriyama, et al.
Published: (2015)